Docs and sources: OpenAI closed a $300M+ share sale at a $27B-$29B valuation; backers include Tiger Global, Sequoia, a16z, Thrive, K2 Global, and Founders Fund
Updated to note that the Microsoft investment closed in January. The money from VCs reported here, part of a tender offer, is separate to that.
Context & Ripple Effects
This tender closes the gap left open when [[a:984046|OpenAI entered advanced talks with Microsoft after a 2021 raise at an implied ~$20B valuation]] from Sequoia, Tiger Global and a16z. The $300M+ secondary at $27B-$29B is the first hard mark on the cap table since those talks began, and it lands alongside Microsoft's January-closed investment rather than replacing it.
The buyer list matters as much as the price: Thrive, which also ran the later $80B employee cash-out tender and led the record $6.6B round at $157B, was already inside at this earlier mark. This story is the rung where the current backer syndicate formed.
First-order effects
- Employees and early holders of OpenAI shares get liquidity at a price up roughly a third above the implied 2021 mark, without a new primary raise diluting the company.
- Tiger Global, Sequoia, a16z, Thrive, K2 Global and Founders Fund convert interest into allocated positions ahead of the ChatGPT-era repricing.
Second-order effects
- The tender structure itself becomes OpenAI's preferred liquidity mechanism: the same format recurs in the $80B employee cash-out led by Thrive, letting the company mark value upward between primary rounds while retaining equity.
- Repeat participation compounds allocator advantage — Thrive's early position at $27B-$29B gives it standing to lead progressively larger deals, squeezing funds that waited for later marks.
Third-order effects
- If the pattern holds, frontier labs are priced less by traditional funding rounds than by a recurring cycle of employee-share tenders run by a small, stable syndicate of crossover and venture firms — concentrating frontier-lab ownership among repeat backers rather than broadening it.
The trend: Private AI labs are building their valuations through successive employee-share tenders run by an increasingly concentrated set of repeat backers, turning secondary sales into the sector's de facto pricing mechanism.